Bio

Eli Lilly to Acquire Versanis Bio, Maker of Obesity Treatment

Versanis shareholders could receive as much as $1.925 billion in cash, which will consist of an upfront payment and additional…

2 years ago

Maxim Group Upgrades Palisade Bio (PALI)

On March 30, 2023, Maxim Group upgraded their outlook for Palisade Bio (NASDAQ:PALI) from Hold to Buy. Analyst Price Forecast…

2 years ago